Why Praxis Precision Medicines Inc (NASDAQ:PRAX) Stock went up 171.60% in Last Year?
Robert W. Baird raised the price target for the Praxis Precision Medicines Inc (NASDAQ:PRAX) stock to “an Outperform”. The rating was released on May 01, 2024, according to finviz. The research report from Wedbush has downgraded the stock from Outperform to Neutral, with a price target set at $4. The stock was initiated by H.C. […]
Praxis Precision Medicines Inc (NASDAQ:PRAX) Stock Price Advanced 1.90% to $47.78
Truist raised the price target for the Praxis Precision Medicines Inc (NASDAQ:PRAX) stock to “a Buy”. The rating was released on September 19, 2023, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $48. The stock was initiated by BofA Securities, who disclosed […]
